Dan Evans fails drugs test after testing positive for cocaine


Embed from Getty Images

By Ros Satar

  • Dan Evans calls an press conference at a hotel near Queen’s Club to announce his suspension on Friday
  • Yet to learn how long his suspension will be
LONDON, UK – British No. 3 Dan Evans announced that he has failed a drugs test, testing positive for cocaine.


Dan Evans has failed a drugs test, he announced on Friday. While the quarter-finals were being played at Queen’s Club, he called a hastily arranged press conference at a hotel near the venue to tell press he had failed a test in April, testing positive for cocaine.

As reported by BBC Sport Twitter Evans read a pre-prepared statement, and was not permitting questions:

Full Transcript of Dan Evans’ Statement

“This is a very difficult day for me and I wanted to come here in person and tell you [guys] face-to-face I was notified a few days ago that I failed a drugs test in April, where I tested positive for cocaine.

“It is really important that you know this was taken out of competition and the context completely unrelated to tennis. I made a mistake and I must face up to it. I do not condone for one second to anyone that this was acceptable behaviour. I have let a lot of people down – my family, my coach, my team, sponsors, British tennis and my fans.

“I can only deeply apologise from the bottom of my heart. It is a sad and humbling experience. I hope you understand I will not be taking any questions and I thank you for your support of my career to date.”

Evans has also deleted both his Instagram and Twitter accounts.


ITF/Tennis Anti Doping Programme statement

Following the statement made by Daniel Evans today, the Tennis Anti-Doping Programme (TADP) can confirm the following:
– On 24 April 2017, Mr Evans, a 27-year-old player from Great Britain, provided an anti-doping sample to the TADP in association with his participation in the Barcelona Open, an ATP World Tour event, held in Barcelona, Spain.
– That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory in Montreal, Canada, and was found to contain cocaine and its metabolite. Cocaine is a Non-Specified substance prohibited under category S6 of the 2017 WADA Prohibited List (stimulants), and therefore is also prohibited under the TADP.
– In accordance with Article 2.1 of the TADP, Mr Evans was charged on 16 June with an Anti-Doping Rule Violation.
– Mr Evans has accepted the finding of cocaine in his sample collected on 24 April.
– As positive tests for Non-Specified Substances carry a mandatory Provisional Suspension, Mr Evans will be provisionally suspended with effect from 26 June, under Article 8.3.1(c) of the 2017 TADP, pending determination of the case.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.